Shenzhen Chipscreen Biosciences Co. Ltd.SSE: 688321

Announcement on Abnormal Fluctuations in Stock Trading

Jul 4, 2025 · Issued by Shenzhen Chipscreen Biosciences Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Jul 4, 2025

On 6ix: 6ix.com/news/announcement-on-abnormal-fluctuations-in-stock-trading-865

Announcement on Abnormal Fluctuations in Stock Trading

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shenzhen Chipscreen Biosciences Co. Ltd. on 6ix

Later from Shenzhen Chipscreen Biosciences

Announcement on Voluntary Disclosure of Top-line Analysis Data of Phase III Clinical Trial of Chidamide as the First-line Treatment for Diffuse Large B-cell LymphomaJul 10, 2025
Announcement on Voluntary Disclosure of Semi-annual Earnings Preannouncement for 2025Jul 18, 2025
Chipscreen Biosciences' Brain-Penetrant Aurora B Selective Inhibitor CS231295 Tablet Receives FDA IND Approval, Advancing Global Clinical DevelopmentJul 31, 2025
Announcement on Convening the 2025 Semi-annual Performance BriefingAug 15, 2025
Announcement on Continuing to Use Temporarily Idle Raised Funds for Cash ManagementAug 19, 2025

All Shenzhen Chipscreen Biosciences news releases

Follow Shenzhen Chipscreen Biosciences into a list and get an email when it puts out news.

Follow Shenzhen Chipscreen Biosciences